| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0287230216965525 | -0.0053983645 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0287230216965525 | 0.21367854 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.0287230216965525 | -0.016288506 |
| NSC 96996 | B 169 | 0.0287230216965525 | 0.32984633 |
| NSC 133072 | Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) | 0.0287337488682932 | 0.15104202 |
| NSC 224131 | N-Phosphonacetyl-L-aspartate | 0.0287337488682932 | 0.07999922 |
| NSC 289922 | Phosphonium, triphenyl-1-propenyl-, bromide, (E)- (9CI) | 0.0287337488682932 | 0.12911174 |
| NSC 31709 | Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride | 0.0287337488682932 | 0.27936058 |
| NSC 351907 | MASTOPARAN | 0.0287337488682932 | -0.1430058 |
| NSC 371488 | 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride | 0.0287337488682932 | 0.28577159 |